Surmodics, Inc.
Surmodics, Inc. (SRDX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SRDX · as of Jun 8, 2026
Key Statistics
Explore Surmodics, Inc. Data
srdx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 57.1%
The SRDX analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $39.50, representing -8.10% downside from the current price of $42.98.
Competitors & Peers
srdx competitorsSRDX
BVS
CBLL
CCRN
KIDS
LABStock Performance
Full HistoryAbout Surmodics, Inc.
Surmodics, Inc. together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and mic…
what is surmodics, inc. · srdx stock overview · surmodics, inc. company profile · who is surmodics, inc. ceo · srdx NASDAQ · surmodics, inc. headquarters · surmodics, inc. business segments
About Stock Overview & Key Data
Surmodics, Inc. (SRDX) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Mar 4, 1998. As of the latest trading session, SRDX stock price is $42.98, with a market capitalization of $614.5M. The stock has returned +8.34% over the past 12 months and +8.32% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Surmodics, Inc. stock is Buy, with an average 12-month price target of $39.50. In fiscal year 2024, Surmodics, Inc. reported revenue of $126.1M and net income of -$11.5M. For detailed data — including Surmodics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Surmodics, Inc. (SRDX) stock price is $42.98. The stock is traded on NASDAQ under the ticker symbol SRDX. The 52-week range is $25.87 – $43.00.